Testing effectiveness (Phase 2)Study completedNCT01113398What this trial is testingAMG 102 and Avastin for Recurrent Malignant GliomaWho this might be right forGlioblastoma MultiformeGliosarcoma Katy Peters 36
Large-scale testing (Phase 3)Study completedNCT00052455What this trial is testingTemozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Institute of Cancer Research, United Kingdom 500
Early research (Phase 1)Study completedNCT05362409What this trial is testingStudy to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade GliomaWho this might be right forHigh Grade Glioma Alpheus Medical, Inc. 22
Not applicableStudy completedNCT04446416What this trial is testingEfficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsWho this might be right forGlioblastoma MultiformeGlioblastomaGlioma+3 more NaviFUS Corporation 6
Testing effectiveness (Phase 2)Temporarily pausedNCT05183204What this trial is testingPaxalisib With a High Fat, Low Carb Diet and Metformin for GlioblastomaWho this might be right forGlioblastoma Weill Medical College of Cornell University 33
Early research (Phase 1)Study completedNCT01308684What this trial is testingA Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent GlioblastomaWho this might be right forGlioblastoma Multiforme Hoffmann-La Roche 22
Early research (Phase 1)Study completedNCT00003348What this trial is testingCarmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the BrainWho this might be right forBrain and Central Nervous System Tumors Duke University 56
Testing effectiveness (Phase 2)Ended earlyNCT02047214What this trial is testingSafety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin TherapyWho this might be right forGlioblastoma Multiforme Cortice Biosciences, Inc. 17
Testing effectiveness (Phase 2)Looking for participantsNCT07301268What this trial is testingGI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 AstrocytomaWho this might be right forGlioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more Mayo Clinic 36
Testing effectiveness (Phase 2)Ended earlyNCT04915404What this trial is testingBerubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)Who this might be right forRecurrent Glioblastoma Multiforme WPD Pharmaceuticals Sp. z o.o. 5
Early research (Phase 1)Not Yet RecruitingNCT07579208What this trial is testingA Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent GlioblastomaWho this might be right forPhase 1NK CellIL13Ra+4 more M.D. Anderson Cancer Center 36
Very early researchLooking for participantsNCT05432518What this trial is testingPilot Trial for Treatment of Recurrent GlioblastomaWho this might be right forGlioblastomaRecurrent DiseaseRecurrent Glioblastoma AHS Cancer Control Alberta 10
Early research (Phase 1)Study completedNCT00612638What this trial is testingPh. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic GliomasWho this might be right forGlioblastomaGliosarcoma Duke University 96
Testing effectiveness (Phase 2)Study completedNCT00329719What this trial is testingSorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent GlioblastomaWho this might be right forAdult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm National Cancer Institute (NCI) 115
Very early researchStudy completedNCT00864864What this trial is testingSunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent GlioblastomaWho this might be right forGlioblastomaBrain Tumor Massachusetts General Hospital 8
Early research (Phase 1)Ended earlyNCT02433392What this trial is testingStudy of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.Who this might be right forGlioma Boston Scientific Corporation 9
Testing effectiveness (Phase 2)WithdrawnNCT01249105What this trial is testingMK-2206 for Recurrent Malignant GliomaWho this might be right forMalignant Glioma Dana-Farber Cancer Institute
Very early researchActive Not RecruitingNCT06824662What this trial is testingPhase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype GlioblastomasWho this might be right forGlioblastoma WHO Grade IV Nader Sanai 30
Early research (Phase 1)Ended earlyNCT01122888What this trial is testingCilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00002754What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer Duke University 6